male reproductive cancers

Card Set Information

Author:
RadTherapy
ID:
205513
Filename:
male reproductive cancers
Updated:
2013-03-07 14:59:00
Tags:
powerpoint review
Folders:

Description:
tracey's test
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user RadTherapy on FreezingBlue Flashcards. What would you like to do?


  1. BPH?
    benign prostatic hyperplasia
  2. PSA?
    prostate specific antigen (under 1 is good)
  3. Treat the ____ prostate.
    whole
  4. ____ cell patients do better than adeno.
    Squamous
  5. AFP?
    alpha feta protein
  6. hockey stick shape field is always ____?
    seminoma
  7. Prostate
    testicular
    penile/urethra     
    how common??
    • most common
    • rare
    • very rare
  8. Incidence of prostate ca:
    ____ although there appears to be some ____ relationship.
    Often found concurrently w/ ____ ____ ____.
    • unknown
    • hormonal
    • benign prostatic hyperplasia
  9. Penile/male urethra incidence:
    Higher in ?
    Penile ca is related to ____ ____?
    Urethral ca is linked to chronic ____ and infections, ____, ____ diseases, and stictures.
    • Asia, Africa, South America
    • neonatal circumcision
    • irritation
    • HPV
    • venereal
  10. Testicular cancers are rare, but ____ common ____ in men ages 20-34. Incidence is higer in males w/ ____ ____. (cryptoorchidism) Most common in ____ from the US, UK, and Denmark.
    • most
    • malignancy
    • undescended
    • testes
    • caucasians
  11. Pathology:
    prostate- ____ is most common.
    penile lesions- well differentiated ____ ____.
    urethral lesions-well to moderately   differentiated ____ ____.
    prostatic urethral lesions- ____ ____.
    bulbomembranous urethral lesions-____.
    testicular- 95% ____ cell. (seminoma 35-50%)
    • adenocarcinoma
    • squamous cell
    • squamous cell
    • transitional cell
    • adenocarcinomas
    • germ
  12. TURP?
    transurethral resection of the prostate
  13. Most common age:
    prostate-
    penile/urethra-
    testicular-
    • after age 65
    • 58-60
    • between ages 20-34
  14. XRT doses:PROSTATE
    nodal doses?
    seminal vesicle?
    prostate?
    • 45-50Gy
    • 54-56Gy
    • 72-80Gy
  15. XRT dose for penile/urethra ____Gy?
    include ____ nodes.
    • 65-70
    • inguinal
  16. XRT dose: TESTES
    seminoma- ____cGy for stage I and stage IIA, boost of ____ -____cGy for stage IIA and higher.
    nonseminoma (____) RT has ____ role in these tumors, except ____ of brain or other mets areas.
    • 2500
    • 500-600
    • radioresistant
    • little
    • palliation
  17. Histology: PROSTATE
    Cancer is ____ and developes in the ____ of the prostate. Benign is ____. ____ invasion is ____ is most ____ cases.
    • multifocal
    • peripheral
    • central
    • Perineural
    • present
    • all
  18. Detection and Diagnoses: PROSTATE
    (7) CCCDPMT
    • -complete physical & rectal exams
    • -cystocopy
    • -CT
    • -diagnosis obtained through a trasrectal sonography guided needle biopsy
    • -PSA (normal is 4ng/ml or less)
    • -MRI
    • -transurethral ultrasound
  19. ____ is used for staging prostate ca.
    Gleason
  20. Prostate ca is the most common ____ in men. _:_ will develope in their lifetime. ____ ____ have one of the highest ____ in the world and a worse ____. Incresed risk in ____, Sweden, and ____. Decreased risk in ____, Taiwan, and ____ ____. Overall a slow growing malignancy.
    • malignancy
    • 1:6
    • African Americans
    • incidences
    • prognosis
    • US
    • Europe
    • Japan
    • Jewish men
  21. Prognostic factors for prostate ca? (4) (TRPL)
    • Tumor stage
    • Race
    • PSA
    • Lymph node status
  22. As prostate ca grows, it may ____ into and through the ____ , invade ____ tissue, ____ vesicales and eventually the ____ or ____.
    • extend
    • capsule
    • periprostatic
    • seminal
    • bladder
    • rectum
  23. Treatment techniques for prostate ca?
    ____ for patients over 75. ____ T1 or T2 stage disease and life expectancy of at least 10 years. ____ ____ regresses prostate tumor. ____ mostly used for mets disease. ____ ____ positively charged particles deliver dose. (Bragg's peak)
    • observation
    • prostatectomy
    • hormonal therapy
    • chemotherapy
    • proton therapy
  24. Hormonal therapy examples? (4)
    • Zoladex
    • Lupron
    • Flutamide
    • Casodex
  25. Testes routes/sites of spread.
    seminoma: ____ to lymph nodes of ____, mediastinal, and ____ nodes. Only ____ stage disease spread hematogenously to the ____, bone, ____ or brain.
    • Orderly
    • retroperitoneum
    • scv
    • late
    • lung
    • liver
  26. Testes:
    nonseminomas- metastasize outside the ____ ____ involving lungs and ____.
    • Lymph nodes 
    • liver
  27. Prostate major sites of spread are ____ and ____ ____. Blood goes to the ____, liver, and ____. Lymph nodes spread first to ____ and ____ nodes, followed by external ____, hypo gastric, common iliac, and ____ ____.
    • Blood 
    • lymph nodes
    • bone
    • brain
    • Periprostatic 
    • obturator
    • iliac 
    • para aortics

What would you like to do?

Home > Flashcards > Print Preview